Allstate Corporation’s Jazz Pharmaceuticals JAZZ Stock Holding History

Allstate Corporation’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.39M	Buy	+7,332	New	+$1.28M	0.01%	677
2020 Q2	–	Sell	-2,215	Closed	-$221K	–	696
2020 Q1	$221K	Sell	2,215 -9,606	-81%	-$1.24M	0.01%	569
2019 Q4	$1.76M	Sell	11,821 -363	-3%	-$49.4K	0.03%	326
2019 Q3	$1.56M	Buy	12,184 +3,237	+36%	+$434K	0.03%	323
2019 Q2	$1.27M	Buy	+8,947	New	+$1.2M	0.02%	360
2019 Q1	–	Sell	-3,868	Closed	-$479K	–	421
2018 Q4	$479K	Buy	+3,868	New	+$574K	0.02%	330
2017 Q3	–	Sell	-12,626	Closed	-$1.96M	–	147
2017 Q2	$1.96M	Sell	12,626 -8,635	-41%	-$1.32M	0.1%	86
2017 Q1	$3.09M	Sell	21,261 -21,840	-51%	-$2.84M	0.19%	81
2016 Q4	$4.7M	Buy	+43,101	New	+$4.8M	0.28%	112

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Allstate Corporation's JAZZ Position: Q1 2026 in Review

Allstate Corporation opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 7,332 shares worth $1.39M. The stake represents 0.01% of the portfolio and ranks #677 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in JAZZ as recently as Q1 2020.

Allstate Corporation first reported a position in JAZZ in Q4 2016 and has held it in 9 quarters since. The position peaked at $4.7M in Q4 2016. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Allstate Corporation held 7,332 shares of Jazz Pharmaceuticals worth $1.39M as of Q1 2026.
Jazz Pharmaceuticals was a new Allstate Corporation position in Q1 2026.
Jazz Pharmaceuticals made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #677 holding.
Allstate Corporation first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 9 quarters since.
Allstate Corporation's Jazz Pharmaceuticals position peaked at $4.7M in Q4 2016.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.